Pandox
kr 151.00Change from previous close: −0.40%Absolute change: −kr 0.60
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- kr 29.39B
- Enterprise value
- kr 82.83B
- P/E (trailing 12 months)
- 9.22
- Forward P/E
- 13.8
- Price/book
- 0.85
- Price/sales
- 3.71
- EV/EBITDA
- 17.3
- EV/revenue
- 10.5
Profitability and growth
- Gross margin
- 59.7%
- Operating margin
- 61.1%
- Net margin
- 40.2%
- ROE
- 9.5%
- ROA
- 2.8%
- Revenue growth (year over year)
- 14.8%
- Earnings growth (year over year)
- -68.4%
Financial health
- Total cash
- kr 1.64B
- Total debt
- kr 54.78B
- Debt/equity
- 1.57
- Current ratio
- 0.80
- Quick ratio
- 0.13
Dividends
- Annual dividend per share
- kr 4.50
- Dividend yield
- 3.0%
- Payout ratio
- 27.5%
- Ex-dividend date
- April 16, 2026
Analysts and estimates
- Average price target
- kr 204.60
- Median price target
- kr 190.00
- High price target
- kr 245.00
- Low price target
- kr 180.00
- Analysts with a price target
- 5
- Consensus
- Strong buy
- Forward EPS
- kr 10.94
- EPS estimate, current year
- kr 11.72
Shares and trading
- Beta
- 1.23
- Average volume
- 105.22K
- Shares outstanding
- 119.6M
- Float
- 105.31M
- Institutional ownership
- 79.0%
- Insider ownership
- 11.9%